Novartis Investigative Site

Tlalpan, Mexico City 14080

2 studies enrolling now · 3 studies all time

What they study most

Early Breast Cancer, Primary Prevention of Atherosclerotic Cardiovascular Disease, Progressive Metastatic Castrate Resistant Prostate Cancer

Studies at this site

• Phase IIIb Study of Ribociclib + ET in Early Breast Cancer — Recruiting now
• An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01) — Recruiting now
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling